Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States

Ryan Connolly, K.; Helmer, Amanda; A. Cristancho, Mario; Cristancho, Pilar; P. O’Reardon, John

doi:10.4088/jcp.11m07413

Public

Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States

Published in The Journal of Clinical Psychiatry • Apr 15, 2012

Authors:

K. Ryan Connolly

Amanda Helmer

Mario A. Cristancho

Abstract

INTRODUCTION: Transcranial magnetic stimulation (TMS) is a US Food and Drug Administration-approved treatment for major depressive disorder (MDD) in patients who have not responded to 1 adequate antidepressant trial in the current episode. In a retrospective cohort study, we examined the effectivene...

Subject

Beck Depression Inventory

Major depressive disorder

Major depressive episode

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!